skip to Main Content
AIM-HI Accelerator Fund
SIGN UP
DONATE
MENUMENU
  • About
    • Our Vision
    • Our Story
    • Our Team
      • Leadership Team
      • Board of Directors
      • Advisors
    • Our Partners
  • Programs
    • Women’s Venture Competition
    • Accelerator Program
    • Our Portfolio Companies
  • News
    • Press Release
    • Blog
    • Media
  • Contact Us
    • Fellowship Opportunity
  • Get Involved
    • Donate to AIM-HI
    • Donor Advised Fund
    • Buscemi Memorial Fund
DONATE
SIGN UP
DONATE
SIGN UP
MENUMENU
  • About
    • Our Vision
    • Our Story
    • Our Team
      • Leadership Team
      • Board of Directors
      • Advisors
    • Our Partners
  • Programs
    • Women’s Venture Competition
    • Accelerator Program
    • Our Portfolio Companies
  • News
    • Press Release
    • Blog
    • Media
  • Contact Us
    • Fellowship Opportunity
  • Get Involved
    • Donate to AIM-HI
    • Donor Advised Fund
    • Buscemi Memorial Fund

News

Home » News

AIM-HI Accelerator Fund Portfolio Company Receives Virginia Catalyst Funding

  • December 30, 2019
  • News, Press Release

ROCKVILLE, MD – A portfolio start-up company of the AIM-HI Accelerator Fund has been awarded $700,000 from Virginia Catalyst to commercialize its lead cancer drug candidate. Richmond-based InterLeukin Combinatorial Therapies (ILCT) is developing unique engineered therapeutic interleukins (a type of…

cancer research image

Disruptive Funding Model to Advance Innovations—A New Approach to Ending Cancer for Each and for All

  • September 3, 2019
  • Blog, News

The National Foundation for Cancer Research funds “high risk|high reward” research with a singular focus on one absolute and immutable goal: research to cure cancer – cures for all types of cancer. Since 1973 with grass roots support of Americans…

  • Previous
  • Page 1
  • Page 2
  • Page 3

Sign Up for Our News

Follow Us
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
Recent Posts
  • Support Women Scientist-Entrepreneurs in Celebration of the Women’s Equality Day
    August 25, 2020
  • AIM-HI Portfolio Company Profile: Rasio Therapeutics
    August 10, 2020
  • AIM-HI Announces Semi-Finalists in Women’s Venture Competition, Finalists Announced Sept. 24
    August 7, 2020
Search
Total WordPress Theme

Funding start-up oncology companies commercializing innovative lab breakthroughs.


Contact Us

Address:
5515 Security Lane, Suite 1105
Rockville, MD 20852

Phone:1-800-321-CURE (2873)
Email:info@aim-hiaccelerator.org

AIM-HI Accelerator is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #:82-4322538

Follow Us
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Copyright 2020 - All Rights Reserved

Website designed and maintained by USABAL Solutions

Back To Top
×